Aortic valve replacement up in patients with Alzheimer’s disease
Sep 17, 2021
One-year outcomes were similar for patients with or without Alzheimer’s disease and related dementias.
Most with Alzheimer’s disease, mild cognitive impairment would have been excluded from aducanumab...
Sep 16, 2021
Overall, 92.2, 91, and 85.5% of Medicare beneficiaries with Alzheimer’s disease-related disorders, Alzheimer’s disease, and mild cognitive impairment met at least one of the exclusion criteria.
Widespread pain tied to dementia, Alzheimer’s disease, stroke
Aug 17, 2021
After adjustment for multiple variables, widespread pain appeared to increase subsequent risk.
Global dementia cases projected to top 152 million in 2050
Jul 29, 2021
Increases in cases were mainly due to population growth and aging, with the relative importance of these factors varying by region.
Relapse risk for psychosis in dementia lower with continued pimavanserin
Jul 22, 2021
The findings were seen in a double-blind, randomized, placebo-controlled discontinuation trial that was stopped early for efficacy.
Medicare mulls coverage for controversial drug for Alzheimer’s disease
Jul 13, 2021
CMS says a final decision on coverage is not likely until next spring.
New Rx instructions tighten use of controversial Alzheimer’s disease drug
Jul 08, 2021
Major changes to prescribing instructions are rare, especially so soon after approval; it change could curb the drug’s use.
Lilly to seek FDA approval for new drug for Alzheimer’s disease
Jun 25, 2021
Donanemab already has received a ‘breakthrough therapy’ designation from the FDA.